Disposition and metabolism of [
Administration, Oral
Animals
Macaca fascicularis
Male
Metabolic Networks and Pathways
Orexin Receptor Antagonists
/ administration & dosage
Pyridines
/ administration & dosage
Pyrimidines
/ administration & dosage
Rats, Sprague-Dawley
Sleep Aids, Pharmaceutical
/ administration & dosage
Tissue Distribution
Lemborexant
disposition
hypocretin
metabolism
orexin
Journal
Xenobiotica; the fate of foreign compounds in biological systems
ISSN: 1366-5928
Titre abrégé: Xenobiotica
Pays: England
ID NLM: 1306665
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
29
5
2018
medline:
13
9
2019
entrez:
29
5
2018
Statut:
ppublish
Résumé
The disposition and metabolism of lemborexant, a novel dual orexin receptor antagonist currently under development as a therapeutic agent for insomnia disorder, were evaluated after a single oral administration of [
Identifiants
pubmed: 29806508
doi: 10.1080/00498254.2018.1482509
doi:
Substances chimiques
Orexin Receptor Antagonists
0
Pyridines
0
Pyrimidines
0
Sleep Aids, Pharmaceutical
0
lemborexant
0K5743G68X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM